Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedA 403 Forbidden error page is now shown for the study page, replacing the previous detailed study information with a standard error screen and a Home link. This indicates the page is currently inaccessible due to access restrictions.SummaryDifference17%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s underlying version. This change does not appear to modify the study details or user-facing content.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update to the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page displays a new revision label indicating v3.6.4, replacing the previous v3.6.3. This change represents a software version update and does not modify the study data or visible content.SummaryDifference0.0%

- Check82 days agoChange DetectedThe study documents now show Revision: v3.6.3, updating from v3.6.2. This indicates an updated protocol/document for the trial.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision changed from v3.6.0 to v3.6.2 on the page, reflecting a newer software release. It is a minor patch update and does not modify the study content or public-facing information.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.